These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20726269)

  • 1. [Analysis on neutralization antibody titer of Japanese B encephalitis virus in healthy population in Shaanxi province].
    Zhang SB; Li P; Liu XZ
    Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):251-3, 257. PubMed ID: 20726269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemic characteristics and viral antibody level among healthy people of Japanese B encephalitis in Henan province in 2010].
    Tang XY; Kang K; Shang SY; Xu C; Li XL; Ma HX; Chen HM; Xu BL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Oct; 46(10):888-91. PubMed ID: 23363861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.
    Bonaparte M; Dweik B; Feroldi E; Meric C; Bouckenooghe A; Hildreth S; Hu B; Yoksan S; Boaz M
    BMC Infect Dis; 2014 Mar; 14():156. PubMed ID: 24656175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on surveillance data regarding the level of Japanese encephalitis antibody in Heilongjiang. province, 2006].
    An ZJ; Ma YJ; Bo F; Huang H; Zhang ST
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Dec; 28(12):1186-9. PubMed ID: 18476578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibody rather than cellular immune response is maintained for nearly 20 years among Japanese encephalitis SA14-14-2 vaccinees in an endemic setting.
    Wang R; Fan D; Wang L; Li Y; Zhou H; Gao N; An J
    Infect Genet Evol; 2020 Nov; 85():104476. PubMed ID: 32736041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Neutralizing Antibody Titers against Japanese Encephalitis Virus Genotype V Strain with Those against Genotype I and III Strains in the Sera of Japanese Encephalitis Patients in Japan in 2016.
    Maeki T; Tajima S; Kyaw AK; Matsumoto F; Miura K; Yamashita A; Yoshikawa A; Negishi K; Noguchi Y; Tadokoro K; Abe K; Taruya J; Koh J; Ito H; Ikegaya A; Abe F; Wada M; Nishigata T; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Morita K; Lim CK; Saijo M
    Jpn J Infect Dis; 2018 Sep; 71(5):360-364. PubMed ID: 29962489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the genotypic characteristics of Japanese encephalitis virus and serology in the healthy population of Zhejiang province, 2012-2013].
    Yan J; Pan J; Zhang Y; Zhou J; Ni H; Zhang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Oct; 35(10):1146-50. PubMed ID: 25567023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance of healthy people's Japanese encephalitis neutralizing antibody in some areas of Henan Province].
    Tang XY; Ma HX; Xu C; Shang SY; Kang K; Huang XY; Yin ZD; Wang HY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):401-4. PubMed ID: 22734219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and laboratory assay of adult Japanese encephalitis patients in an outbreak in Yuncheng, Shanxi Province, 2006].
    Zhang DL; Ma LB; Fu SH; Wang LH; Wang HY; Zhang M; Wei ZG; Li GG; Cui XF; Lei HG; Sun XH; Lv XJ; Li MH; Liang GD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):95-7. PubMed ID: 18574525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and molecular epidemiology of Japanese Encephalitis in Zhejiang, China, 2015-2018.
    Deng X; Yan JY; He HQ; Yan R; Sun Y; Tang XW; Zhou Y; Pan JH; Mao HY; Zhang YJ; Lv HK
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008574. PubMed ID: 32853274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children.
    Ku CC; King CC; Lin CY; Hsu HC; Chen LY; Yueh YY; Chang GJ
    J Med Virol; 1994 Oct; 44(2):122-31. PubMed ID: 7852952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization Potency of Sera from Vietnamese Patients with Japanese Encephalitis (JE) against Genotypes I and V JE Viruses.
    Nguyen TTT; Tajima S; Ikeda M; Nguyen TT; Le TTH; Pham HTT; Pham DQ; Le MTQ; Maeki T; Taniguchi S; Kato F; Moi ML; Morita K; Lim CK; Saijo M; Hasebe F
    Jpn J Infect Dis; 2019 Mar; 72(2):115-117. PubMed ID: 30381682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreases in Both the Seroprevalence of Serum Antibodies and Seroprotection against Japanese Encephalitis Virus among Vaccinated Children.
    Wang R; Xie L; Gao N; Fan D; Chen H; Wang P; Zhou H; An J
    Virol Sin; 2019 Jun; 34(3):243-252. PubMed ID: 30911897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010.
    Lee EJ; Cha GW; Ju YR; Han MG; Lee WJ; Jeong YE
    PLoS One; 2016; 11(1):e0147841. PubMed ID: 26807709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis on data from the clinical acute viral encephalitis surveillance system in three prefectures in Shaanxi during 2005 - 2006].
    Zhang SB; Yin ZD; Suraratdecha C; Hills SL; Liu XZ; Li YX; Xia XQ; Liang GD; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):895-8. PubMed ID: 19173854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention of neutralizing antibodies to Japanese encephalitis vaccine in age groups above fifteen years in Korea.
    Lee HJ; Choi H; Park KH; Jang Y; Hong YJ; Kim YB
    Int J Infect Dis; 2020 Nov; 100():53-58. PubMed ID: 32829050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.